Non, le vaccin contre la variole du singe n’est pas expérimental

Non, le vaccin contre la variole du singe n’est pas expérimental

More than 2,000 cases of monkeypox have been detected worldwide and the outbreak has been classified as an international emergency. There are treatments and a vaccine. But for some Internet users, receiving this new injection would be like participating in a clinical trial. And even the World Health Organization would say so.

According to an article widely shared on social media, the head of the WHO Global Infectious Risks Preparedness Unit, Tim Nguyen, said: “I would like to highlight one thing that is very important to the WHO. We are uncertain about the effectiveness of these vaccines because they have not been used before in this setting and on this scale. »

Like an air of deja vu since the debates were similar during the commercialization of the vaccines against Covid-19. “We are free guinea pigs for them,” launches a user. “The government is not telling us these bites are unreliable by asking us to be bitten! another protests. Has the WHO really claimed that getting vaccinated against monkeypox is like taking part in a clinical trial? 20 minutes Make the point.

FAKE

The article cited by netizens is based on a video of a press conference. “I would like to point out something that is very important to the WHO, we have doubts about the effectiveness of these vaccines, because they have not been used before in this context and on this scale,” the man said during his speech. Then, a cut in the video can be seen, before continuing: “When these vaccines are in development, they are delivered in the framework of clinical trial studies and the prospective collection of this data to increase our understanding of the effectiveness of these vaccines. . . »

It would be a shortcut to say that with this quote we can understand that getting vaccinated against monkeypox is like participating in a clinical trial. On behalf of the WHO, he does speak about the development phase and a new data collection. As with the Covid-19 vaccines, data is collected throughout the vaccinations. It is important, even once marketed, to monitor the effects and evolution of these products.

In this regard, the European Medicines Agency (EMA) is very clear: “There is a vaccine against monkeypox authorized in the EU, Imvanex, and it is not an experimental vaccine. In fact, the Imvanex vaccine is licensed to protect adults against smallpox and monkeypox, and is marketed as Jynneos in the United States.

“As of July 25, 2022, the Imvanex vaccine obtained the European Marketing Authorization (MA) in the indication of active immunization against monkeypox in adults,” indicates the government vaccine information site. “This new indication is in addition to the existing authorization of Imvanex against smallpox, which has been in force in the EU since 2013,” explains the EMA to 20 minutes.

Furthermore, as he explained last February: “Once a drug has obtained marketing authorization from a regulatory authority, it can no longer be considered an investigational product. »


#vaccin #contre #variole #singe #nest #pas #expérimental

Leave a Reply

Your email address will not be published.